Evidence map›Paper›PMID 36877072›Full record

ArticleJournal of virology2023

SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.

Xuefeng Wang, Wenqi Wang, Tiecheng Wang, Jianzhong Wang, Yuhang Jiang, Xue Wang, Ze Qiu, Na Feng, Weiyang Sun, Chang Li and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Xuefeng Wang *Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.ORCID 0000-0002-3974-3421
Wenqi Wang *Ruminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, China.
Tiecheng WangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Jianzhong WangCollege of Veterinary Medicine, Jilin Agricultural University, Changchun, China.
Yuhang JiangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Xue WangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Ze QiuChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Na FengChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Weiyang SunChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Chang LiChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.ORCID 0000-0002-3267-1859
Songtao YangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Xianzhu XiaChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Hongbin HeRuminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, China.ORCID 0000-0002-7438-0638
Yuwei GaoChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Chinese Academy of Agricultural Sciences · CNShandong Normal University · CNJilin Agricultural University · CNNortheast Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral pathogen responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. The novel SARS-CoV-2 ORF8 protein is not highly homologous with known proteins, including accessory proteins of other coronaviruses. ORF8 contains a 15-amino-acid signal peptide in the N terminus that localizes the mature protein to the endoplasmic reticulum. Oligomannose-type glycosylation has been identified at the N78 site. Here, the unbiased molecular functions of ORF8 are also demonstrated. Via an immunoglobulin-like fold in a glycan-independent manner, both exogenous and endogenous ORF8 interacts with human calnexin and HSPA5. The key ORF8-binding sites of Calnexin and HSPA5 are indicated on the globular domain and the core substrate-binding domain, respectively. ORF8 induces species-dependent endoplasmic reticulum stress-like responses in human cells exclusively via the IRE1 branch, including intensive HSPA5 and PDIA4 upregulation, with increases in other stress-responding effectors, including CHOP, EDEM and DERL3. ORF8 overexpression facilitates SARS-CoV-2 replication. Both stress-like responses and viral replication induced by ORF8 have been shown to result from triggering the Calnexin switch. Thus, ORF8 serves as a key unique virulence gene of SARS-CoV-2, potentially contributing to COVID-19-specific and/or human-specific pathogenesis.

Indexed as

COVID-19Severe acute respiratory syndrome-related coronavirusCalnexinHumansSARS-CoV-2Viral ProteinsVirus ReplicationCalnexinORF8 protein, SARS-CoV-2Viral ProteinsCalnexinendoplasmic reticulum stressORF8SARS-CoV-2

Identifiers

PMID36877072
PMCPMC10062165
OpenAlexW4323293937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.